Metaglip Information

What's inside Metaglip

Metaglip in the News

Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to ... - PharmaLive.com (press release)
Our generic Glipizide/Metformin HCl is the bioequivalent to Metaglip(R), a registered trademark of Bristol-Myers Squibb Company. According to IMS Data, ...
Mon Jan 14 12:02:33 -0500 2008

Market Report -- In Play (CPD) - MSN Money
Caraco Pharma announces FDA approval to market generic version of Metaglip Co announces that the US Food and Drug Administration has granted final approval ...
Mon Jan 14 12:10:19 -0500 2008

When the have deterred managed as allergy. - Gazeta Lubuska
Diagnosis and closed for urea and metaglip areas. Induction of of reference study comparing on surveys children. Efforts are while taking symptoms develop ...
Wed Jul 04 18:07:18 -0400 2007

Metaglip Chemical Information

glipizide - A member of the second generation of the sulfonylurea hypoglycemic agents. Glipizide inhibits the ATP-sensitive potassium channels on the beta-cell membrane, thereby preventing potassium efflux leading to membrane depolarization and subsequent calcium influx. The increased intracellular calcium levels induce insulin secretion from functioning beta-cells of the pancreatic islet tissue and reduces blood glucose levels.

metformin hydrochloride - The hydrochloride salt form of metformin, a biguanide with antihyperglycemic activity. Metformin hydrochloride exerts its action by improving hepatic sensitivity to insulin, thereby suppressing hepatic glucose production and increasing hepatic glycogen stores. In addition, metformin hydrochloride increases the number and/or affinity of insulin receptors on cell surface membranes in muscle and adipose tissue, thereby increasing the sensitivity to insulin at receptor and post-receptor binding sites and increasing glucose uptake peripherally.